Taoyuan County, Taiwan

Shu-Pei Chiu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Shu-Pei Chiu

Introduction

Shu-Pei Chiu is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of nanoparticle technology and radiopharmaceuticals. With a total of 3 patents, his work has the potential to impact cancer treatment and drug delivery systems.

Latest Patents

One of his latest patents is titled "Nanoparticles and method for manufacturing the same." This invention discloses nanoparticles that are primarily composed of albumin and polyethylene glycol, where the albumin is covalently crosslinked with the polyethylene glycol. Another significant patent is "Kit for preparation of target radiopharmaceuticals and method of using it." This invention relates to a kit designed for the preparation of target radiopharmaceuticals, which can inhibit tumor growth and metastatic progression in various cancers, including head and neck cancer, lung cancer, and brain cancer.

Career Highlights

Shu-Pei Chiu has worked with the Institute of Nuclear Energy Research, which is part of the Atomic Energy Council under the Executive Yuan of the Republic of China. His experience in this institution has allowed him to develop innovative solutions in the field of nuclear energy and medical applications.

Collaborations

Some of his notable coworkers include Chih-Hsien Chang and Te-Wei Lee, who have collaborated with him on various projects related to his patents and research.

Conclusion

Shu-Pei Chiu's contributions to nanoparticle technology and radiopharmaceuticals highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving cancer treatment options and enhancing drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…